Welcome to our dedicated page for Roger news (Ticker: ROG), a resource for investors and traders seeking the latest updates and insights on Roger stock.
Rogers Corporation (NYSE: ROG) is a manufacturing company that focuses on engineered materials used in technology-intensive applications. Its news flow reflects developments in its Advanced Electronics Solutions (AES) and Elastomeric Material Solutions (EMS) segments, which serve markets such as EV/HEV, automotive safety and radar systems, mobile devices, renewable energy, wireless infrastructure, aerospace and defense, energy-efficient motor drives and industrial equipment.
On this page, readers can follow ROG news related to quarterly earnings results, segment performance, restructuring actions and governance changes. Recent press releases have covered first, second and third quarter results, highlighting trends in AES and EMS net sales, gross margin, adjusted earnings per diluted share and adjusted EBITDA, as well as the impact of restructuring and impairment charges. These updates also describe demand patterns across end markets like EV/HEV, ADAS, industrial, portable electronics and wireless infrastructure.
Rogers’ news also includes leadership and board updates, such as the appointment of an interim President and Chief Executive Officer, transitions in the Chair of the Board and plans to add a new independent director with input from an institutional investor. The company issues press releases when it schedules earnings calls, providing details on webcasts where management discusses financial performance, cost initiatives and strategic priorities.
Investors, analysts and other followers of ROG stock can use this news feed to track how Rogers’ engineered materials business is evolving, how its restructuring and cost-reduction programs are progressing and how governance and leadership changes may influence its direction. Bookmark this page to quickly access the latest Rogers Corporation earnings announcements, operational updates and corporate disclosures as they are released.
Roche has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, the first immunohistochemistry companion diagnostic test in Europe for identifying epithelial ovarian cancer patients eligible for ELAHERE treatment. The test detects folate receptor 1 protein, expressed in about 90% of ovarian carcinomas. This certification follows an early exemption approval in Germany and Austria earlier this year. The test aims to enable more precise treatment decisions for ovarian cancer, which causes 46,232 deaths annually in Europe and is the eighth leading cause of cancer death in women worldwide.
Rogers (NYSE:ROG) reported mixed Q3 2024 results with net sales of $210.3 million, down 1.8% from Q2. Despite lower sales, earnings exceeded guidance due to operational improvements and expense management. GAAP operating margin improved to 6.9% from 5.3%, while adjusted earnings reached $0.98 per diluted share. The company faced softer EV/HEV demand and lower seasonal peak in portable electronics. Looking ahead, Q4 sales are expected to decline due to seasonality and customer inventory management. The company highlighted its expansion with a new power substrate factory in China targeting EV/HEV, renewable energy, and industrial markets.
Roche has received FDA approval for the VENTANA CLDN18 (43-14A) RxDx Assay, the first companion diagnostic to identify patients with gastric and gastroesophageal junction (GEJ) cancer eligible for targeted treatment with VYLOY. This immunohistochemistry (IHC) assay helps determine CLDN18 protein expression in tumors, enabling clinicians to identify patients who may benefit from Astellas' targeted therapy VYLOY (zolbetuximab).
The assay addresses an unmet medical need by helping predict the likelihood of response to targeted therapy in gastric and GEJ cancers. CLDN18.2 is an emerging biomarker in these cancers. This approval aligns with current guidelines recommending biomarker use to guide therapeutic decision-making in gastric/GEJ cancer.
Gastric cancer is the fifth most common cancer and fourth leading cause of cancer deaths worldwide. In the U.S., 62% of gastric/GEJ cancer cases are advanced at initial diagnosis, with a five-year overall survival rate of only 6%.
Rogers (NYSE:ROG) has announced its plans to release third quarter 2024 financial results on October 24, 2024, after market close. The announcement will be followed by a conference call at 5:00 pm ET, hosted by Colin Gouveia, President and CEO, along with Laura Russell, Interim CFO.
Investors and interested parties can access a live webcast of the event and related slide presentation on Rogers' Investor Relations website. A replay of the event will also be available on the same platform. Rogers is a global leader in engineered materials, specializing in solutions for various industries including automotive, renewable energy, and wireless infrastructure.
Roche's commissioned survey reveals significant gaps in public understanding of HPV and cervical cancer across 12 countries in Latin America and Europe. Key findings include:
- Half of respondents have or no awareness of HPV's role in cervical cancer
- Barriers to screening include fear of pain and discomfort discussing sexual history
- Over 70% of respondents are interested in self-collection options for screening
The survey highlights the need for improved education and accessible screening methods. Roche emphasizes the importance of early detection and prevention, aligning with WHO's goal to eliminate cervical cancer globally. The company has joined the Global HPV Consortium and partners with health systems in over 55 countries to support cervical cancer screening programs using the cobas® HPV test.
Rogers (NYSE: ROG) announced the resignation of CFO Ram Mayampurath, who will remain with the company until September 2024 to ensure a smooth transition. Laura Russell, currently Vice President of Finance, will assume the role of interim CFO effective August 12, 2024. Russell joined Rogers in September 2023 and has previous experience in senior finance roles at Wolfspeed and NXP Semiconductors.
CEO Colin Gouveia expressed gratitude for Mayampurath's contributions over the past 10 years, particularly his efforts in improving profitability and cash flow since becoming CFO in 2021. Rogers has initiated a CFO succession process and will provide updates as appropriate.
Rogers (NYSE:ROG) reported Q2 2024 financial results with net sales of $214.2 million, a 0.4% increase from Q1. GAAP earnings per diluted share were $0.44, up from $0.42 in Q1. Adjusted earnings were $0.69 per diluted share, compared to $0.58 in Q1. The company saw stronger gross margin of 34.1%, up from 32.0% in Q1, driven by favorable product mix and manufacturing cost reductions.
EMS net sales increased by 10.5%, while AES net sales decreased by 5.4%. The company achieved record quarterly sales of EV battery solutions. For Q3 2024, Rogers projects net sales between $215-225 million and adjusted earnings per diluted share of $0.75-$0.95.
Roche (SIX: RO, ROG; OTCQX: RHHBY) will showcase its laboratory of the future exhibit at the 2024 Association for Diagnostics & Laboratory Medicine (ADLM) Scientific Meeting and Clinical Lab Expo in Chicago. The company will unveil next-generation core lab and molecular systems, including a total solution for clinical mass spectrometry. Attendees can experience how Roche's integrated systems and data solutions optimize resources and streamline operations.
Key innovations include the future cobas® Mass Spec solution, new CCM Vertical, cobas® liat system for rapid PCR testing, cobas® pure integrated solutions, cobas® eplex system, cobas® 5800, and cobas® LightCycler® PRO. Roche will also present its navify® digital solutions and host Roche Idea Lab sessions featuring industry experts discussing topics such as mass spectrometry, digital solutions, and respiratory testing.
Rogers (NYSE:ROG) has scheduled its second quarter 2024 earnings call for July 25, 2024, following the market close. The call will begin at 5:00 pm ET and will feature presentations by President and CEO Colin Gouveia and CFO Ram Mayampurath. A live webcast and a related slide presentation will be available on Rogers' Investor Relations website, with a replay accessible post-event. Rogers , based in Chandler, Arizona, is a global leader in engineered materials, providing solutions for EV/HEV, automotive safety, radar systems, mobile devices, renewable energy, and more. The company operates manufacturing facilities in the US, Asia, and Europe, and maintains sales offices worldwide.
Rogers (NYSE: ROG) has released its 2024 Environmental, Social, and Governance (ESG) Report. The report showcases Rogers' commitment to sustainability and corporate responsibility, highlighting achievements in reducing energy consumption, greenhouse gas (GHG) emissions, and water usage. Key targets include a 20% reduction in Scope 1 and Scope 2 GHG emissions by 2030. Additionally, the report details Rogers' efforts in employee safety, development, and ethical governance, aligning with recognized sustainability frameworks such as those by the Sustainability Accounting Standards Board. The full report is available on the company's website.